Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06694558 · ClinicalTrials.gov registry record
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
A clinical trial of Type 1 Diabetes (T1D) and Chronic Kidney Disease(CKD), sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06694558 is a study of Type 1 Diabetes (T1D) and Chronic Kidney Disease(CKD) that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 60 participants, below the 177-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06694558, a study of Type 1 Diabetes (T1D) and Chronic Kidney Disease(CKD), is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a cross-sectional study in patients with Type 1 diabetes (TID) and chronic kidney disease (CKD) to test if time in range (TIR) affects the degree of hyperglycemia required for monocyte activation, podocyte injury, and assess if monocyte activation is attenuated by glucagon-like peptide (GLP-1) agonist treatment ex vivo.
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2026-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06694558
The ClinicalTrials.gov registry entry for NCT06694558 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 177-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (66% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 1 Diabetes (T1D) appearing as the primary indexed condition, and to 0 interventions.
NCT06694558 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06694558 about?
NCT06694558 is a clinical study titled "Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease". This is a cross-sectional study in patients with Type 1 diabetes (TID) and chronic kidney disease (CKD) to test if time in range (TIR) affects the degree of hyperglycemia required for monocyte activation, podocyte injury, and assess if monocyte activation is attenuated by glucagon-like peptide (GLP-...
What is the current status of trial NCT06694558?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2025-03-01. Estimated completion is 2026-07-01.
What conditions does trial NCT06694558 study?
This clinical trial studies the following conditions: Type 1 Diabetes (T1D), Chronic Kidney Disease(CKD).
Who is sponsoring clinical trial NCT06694558?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06694558 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes (T1D)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
RECRUITING · NA
-
Circadian Mechanisms, Glucose, and CV Risks in T1D
RECRUITING · NA
-
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
RECRUITING · NA
-
Twiist Postmarket Surveillance Study for Type 1 Diabetes
RECRUITING
-
Automated Insulin for Management of Intrapartum Glycemia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.